Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Public Health
Published in: BMC Public Health 1/2024

Open Access 01-12-2024 | Tuberculosis | Research

Challenge of ending TB in China: tuberculosis control in primary healthcare sectors under integrated TB control model–a systematic review and meta-analysis

Authors: Xi Chen, Jiani Zhou, Quan Yuan, Rui Zhang, Chunji Huang, Ying Li

Published in: BMC Public Health | Issue 1/2024

Login to get access

Abstract

Background

China has the third-largest burden of tuberculosis (TB) cases in the world with great challenges towards ending TB. Primary health care (PHC) sectors play a critical role in TB prevention and control in communities under the Chinese integrated TB control model. However, there is a lack of comprehensive review of research evidence on TB control in PHC sectors under the integrated TB control model in China.

Methods

This review was conducted following the PRISMA guidelines. Articles published from 2012 to January 2022 were searched from four international and three Chinese databases. Studies conducted inside mainland China and relevant with TB control service in PHC sectors under the integrated model were included. After study selection, data extraction, and quality assessment, the meta-analysis was performed with RevMan using a random-effect model.When I2 was more than 50%, subgroup analysis was performed to explore possible reasons for heterogeneity. We also conducted a post hoc sensitivity analysis for outcomes after meta-analysis by exclusion of studies with a high risk of bias or classified as low quality.

Results

Forty-three studies from 16 provinces/municipalities in China were included in this review, and most studies included were of medium quality. PHC sectors in East China delivered TB control service better overall than that in West China, especially in tracing of patients and TB case management (TCM). In meta-analyses, both the pooled arrival rate of tracing and pooled TCM rate in East China were higher than those in West China. TB patients had a low degree of willingness to receive TCM provided by healthcare workers in PHC sectors nationwide, especially among migrant TB patients. There were 9 studies reporting factors related to TB control service in PHC sectors, 6 (2 in East and 4 in West China) of which indentified several characteristics of patients as associated factors. The context of PHC sectors was demonstrated to influence delivery of TB control service in PHC sectors in 5 studies (3 in East, 1 in Middle and 1 in West China). Most studies on strategies to promoting TB control services in PHC sectors were conducted in East China and some of these studies identified several online and offline interventions and strategies improving patients’ treatment compliance [pooled OR (95% CI): 7.81 (3.08, 19.19] and awareness of TB [pooled OR (95% CI): 6.86 (2.16, 21.72)].

Conclusion

It is of urgent need to improve TB control in PHC sector in China, particularly in West China. Formative and implementation research with rigorous design are necessary to develop comprehensive, context-specific, and patient-centered TB control strategies to promote ending TB in China.
Appendix
Available only for authorised users
Literature
1.
2.
Cluster W. What is DOTS?: a guide to understanding the WHO-recommended TB control strategy known as DOTS. World Health Organization Geneva; 1999.
3.
4.
5.
Ding C, Wang S, Shangguan Y, et al. Epidemic Trends of Tuberculosis in China from 1990 to 2017: evidence from the global burden of Disease Study. Infect Drug Resist. 2020;13:1663–72.PubMedPubMedCentralCrossRef
6.
Wang Q, Li T, Du X, Ni N, Zhao YL, Zhang H. Analysis of the reported incidence of pulmonary tuberculosis in China from 2015 to 2019. Chin J Antituberc. 2021;43(02):107–12. (in Chinese).
7.
Chen W, Zhang H, Du X, Li T, Zhao Y. Characteristics and morbidity of the tuberculosis Epidemic—China, 2019. China CDC Wkly. 2020;2(12):181–4.CrossRef
8.
Deng YL, Liu WP, Zhang TH, Ma Y, Zhang HW. Effects of “12th Five-Year” plan for Tuberculosis Prevention and Control in Shaanxi Province. Occup and Health. 2017;33(16):5. (in Chinese).
9.
Zhang PR, Li T, Xia Y, He JG. Discussion on the construction of a New type of Tuberculosis Control Service System. Chin J Antituberc. 2015;37(10):1070–3. (in Chinese).
10.
Jia X, Chen J, Zhang S, Dai B, Long Q, Tang S. Implementing a “free” tuberculosis (TB) care policy under the integrated model in Jiangsu, China: practices and costs in the real world. Infect Dis Poverty. 2016;5:1.PubMedPubMedCentralCrossRef
11.
Zhang L, Xing W, Zhou J, Zhang R, Cheng Y, Li J, et al. Characteristics of tuberculosis patients in the integrated tuberculosis control model in Chongqing, China: a retrospective study. BMC Infect Dis. 2020;20(1):576.PubMedPubMedCentralCrossRef
12.
13.
Li XY, Huang JY, Lei CY. Current status of health management services for tuberculosis patients. Occup and Health. 2019;35(23):3306–12. (in Chinese).
14.
Liu XJ, Xu Y, Zhang P. Preliminary study on the trinity tuberculosis prevention and control service model in Yichang city. J of Pub Health and Prev Med. 2012;23(5):82–4. (in Chinese).
15.
Gao AH. Analysis of tuberculosis prevention and control work in Duntou town in 2015. J of Clin Med. 2017;4(101):2. (in Chinese).
16.
Li WZ, Hou WL, Yang R, Xu H, Shi OM, Lu ZX. Investigation and analysis of community tuberculosis prevention and control services in Wuhan city. Chin J Dis Control. 2013;17(1):51–3. (in Chinese).
17.
Zheng YH, Liu Y, Zhang YY, Shan LY. Establishment and practice of integrated tuberculosis management model in putuo district of Shanghai. Shanghai J of Prev Med. 2016;28(03):161–4. (in Chinese).
18.
Ye HM, Chen WS, Zhang JF, Liao YF, Chen J, Xu J, et al. Analysis on the effect of community-based TB grading diagnosis and treatment and comprehensive prevention service mode. Elec J of Emerg Infect Dis. 2019;4(1):39–41. (in Chinese).
19.
Zhang HW, Xu J, Ma Y, Deng YL. Evaluation of the implementation effect of health management services for tuberculosis patients in basic public health in Shaanxi Province. Chin J Antituberc. 2019;41(9):951–6. (in Chinese).
20.
Huang W, Long H, Li J, Tao S, Zheng P, Tang S, et al. Delivery of public health services by community health workers (CHWs) in primary health care settings in China: a systematic review (1996–2016). Glob Health Res Policy. 2018;3(1):18.PubMedPubMedCentralCrossRef
21.
Wang Z, Jiang W, Liu Y, Zhang L, Zhu A, Tang S, et al. Transforming tuberculosis (TB) service delivery model in China: issues and challenges for health workforce. Hum Resour Health. 2019;17(1):83.PubMedPubMedCentralCrossRef
22.
Long Q, Guo L, Jiang WX, Huan ST, Tang SL. Ending tuberculosis in China: health system challenges. Lancet Public Health. 2021;6(12):e948–53.PubMedCrossRef
23.
Zhou J, Pu J, Wang Q, Zhang R, Liu S, Wang G, et al. Tuberculosis treatment management in primary healthcare sectors: a mixed-methods study investigating delivery status and barriers from organisational and patient perspectives. BMJ Open. 2022;12(4):e053797.PubMedPubMedCentralCrossRef
24.
Cochrane Collaboration. Review manager (RevMan) [Computer program]. Version 5.0. Copenhagen: The Nordic Cochrane Centre, the Cochrane Collaboration; 2008.
25.
Moher D, Liberati A, Tetzlaff J, Altman D, Group TP. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264–9.PubMedCrossRef
26.
Rostom A, Dube C, Cranney A, Saloojee N, Richmond Sy, Garritty C et al. Celiac Disease. Rockville(M D): Agency for Healthcare Research and Quality (US). 2004. (Evidence Reports/ Technology Assessm ents, No. 104.) Appendix D. Quality Assessment Forms. https://​www.​ncbi.​nlm.​nih.​gov/​books/​NBK35156/​. Accessed 27 Jun 2022.
27.
28.
29.
Higgins J, Green S. Cochrane Handbook for systematic reviews of interventions. Version 5.1.0. The Cochrane Collaboration; 2011.
30.
31.
Cochrane Collaboration. Review manager (RevMan) [Computer program]. Version 5.2. Copenhagen: The Nordic Cochrane Centre, the Cochrane Collaboration; 2012.
32.
Cochran BG. The combination of estimates from different experiments. Biometrics. 1954;10:101–29.CrossRef
33.
Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.PubMedCrossRef
34.
Jiang HX. Analysis of the situation of cooperation in tuberculosis control in Jiangshan city. Zhejiang Prev Med. 2013;25(3):3. (in Chinese).
35.
Xu WX, Hu J, Ge R, Luo JY. Evaluation of efficacy of medical and control cooperation on tuberculosis in Jiaxing city from 2003 to 2013. Chin Rural Health Serv Manag. 2015;35(7):907–9. (in Chinese).
36.
Yang SY, Sun L, Tang LH, Zhao HL, Shen Y, Yi Q, et al. Investigation on knowledge, belief and behavior in prevention and treatment of tuberculosis among residents in rural-urban fringe zone, Shanghai. Chin J of Health Educ. 2016;32(8):697–700. (in Chinese).
37.
Zhong T, Wu GH, Huang JC, Huang YD, Liu SY, Fan YZ, et al. Investigation of factors influencing how tuberculosis patients take medicine under the management of electronic medication system in Nanshan District, Shenzhen. Chronic Pathematology J. 2016;17(2):4. (in Chinese).
38.
Liu T. Current situation and exploration of integrated tuberculosis control at grassroots level. For All Health. 2016;10(8):41–2. (in Chinese).
39.
Chen JH, Zeng JC, Wang T, Wang H, Zhong Q, Chen SD et al. The tuberculosis patients’detection and registration management under the DOTS strategy in Guangdong Province: a qualitative research. J Tuberc Lung Health. 2017;(4):332–5 (in Chinese).
40.
Yin J, Wang X, Zhou L, Wei X. The relationship between social support, treatment interruption and treatment outcome in patients with multidrug-resistant tuberculosis in China: a mixed-methods study. Trop Med Int Health. 2018;23(6):668–77.PubMedCrossRef
41.
Guo WR, Lai JW, Chen JW, Huang Y, Wu SY. Equalization of public health services discovered by tuberculosis patients in migrating population in Panyu District, Guangzhou. Chin Tropl Med. 2019;19(12):1127–31. (in Chinese).
42.
Ou QY, Zhang WH, Luo T, Zhao WJ, Yang R. Investigation and analysis on implementation of tuberculosis health management service project in primary medical institutions in Zhuhai city. Appl Prev Med. 2019;25(2):131–3135. (in Chinese).
43.
Lu QW. Evaluation of the effect of WeChat platform on tuberculosis health education for students in a university in Shanghai. Shanghai Med. 2021;42(16):58–62. (in Chinese).
44.
Zhang LM. Discussion on the effect of hierarchical diagnosis and treatment of tuberculosis and comprehensive prevention and control service mode in tuberculosis prevention and control. Smart Healthc. 2021;7(13):29–31. (in Chinese).
45.
Wu TY. Study on the application effect of tuberculosis control mode in Guangxi. Guangxi Medical University; 2014. (in Chinese).
46.
Li Y, Ehiri J, Oren E, Hu D, Luo X, Liu Y, et al. Are we doing enough to Stem the Tide of Acquired MDR-TB in Countries with High TB Burden? Results of a mixed method study in Chongqing, China. PLoS ONE. 2014;9(2):e88330.PubMedPubMedCentralCrossRef
47.
Huang F, Wang LX, Jiang SW, Liu XQ, Gao YX, Wang XL, et al. The effect analysis of persons with presumed TB referring in primary health care institutions. Chin J Antituberc. 2016;38(12):1061–5. (in Chinese).
48.
Chen W, Li Y, Yang H, Ehiri J, Chen Z, Liu Y, et al. Is tuberculosis health education reaching the public in China? A cross-sectional survey in Guizhou Province. BMJ Open. 2016;6(9):e013534.PubMedPubMedCentralCrossRef
49.
Lin B, Wang HY, Yang FL, Wang XH, Qu YH. Influencing factors of treatment management of pulmonary tuberculosis in Karamay. Chin J of PHM. 2017;33(5):642–4. (in Chinese).
50.
Mi YS. Investigation and research on the current situation of health management of pulmonary tuberculosis patients in Kashi city of Xinjiang. Xinjiang Medical University; 2018. (in Chinese).
51.
Li JH, Zhang L, Wang JY, Lei CY, Yan CP, Liu XL, et al. Analysis on the effect of the pilot of hierarchical diagnosis and treatment and comprehensive prevention and control service model of tuberculosis in Tianshui City, Gansu Province. Chin J Antituberc. 2019;41(8):905–9. (in Chinese).
52.
Pu J, Chen W, Jiang WX, Xing W, Liang SX, Wang G, et al. Is tuberculosis patients management improved in the integrated TB control model in West China? A survey in Guizhou Province, China. Infect Dis Poverty. 2019;8(1):55.PubMedPubMedCentralCrossRef
53.
Ji XF, Yao CL, Guo DQ, Ma XY. Survey of management quality of patients with drug-resistant tuberculosis in Pingliang city from 2015 to 2018. Bull Dis Control Prev. 2020;35(3):74–7. (in Chinese).
54.
He YY, Li JL, Chen W, Luo L, Shang Y, Xu JH. Analysis on the implementation of basic public health tuberculosis service project in Guizhou Province. Stud of Trace Elem and Health. 2020;37(2):54–7. (in Chinese).
55.
Xing W, Zhang R, Jiang W, Zhang T, Pender M, Zhou J, et al. Adherence to Multidrug Resistant Tuberculosis Treatment and Case Management in Chongqing, China - A mixed Method Research Study. Infect Drug Resist. 2021;14:999–1012.PubMedPubMedCentralCrossRef
56.
Ou QY, Zhang WH, Luo T, Zhao WJ, Yang R. SWOT analysis for tuberculosis patient health management services in Zhuhai. J Trop Med. 2019;19(4):515–7. (in Chinese).
57.
Ming H, Tang Y, Xie Y, Xiao T, Wang QZ. Reform in basic public health service-based management on pulmonary tuberculosis patients in Hunan Province: a SWOT analysis. Chin J Public Health. 2019;35(7):907–9. (in Chinese).
58.
Ren PP, Wang B, Chen YH, Tong JC. Effect evaluation of health education on tuberculosis prevention knowledge among urban floating population. Chin J of PHM. 2015;31(2):207–8220. (in Chinese).
59.
Zhou QM, Du YJ. Effect of strengthening health education intervention on pulmonary tuberculosis in floating population. Nurs and Rehabil. 2015;14(2):185–8. (in Chinese).
60.
Yao CB, He YJ. Effect evaluation of health education on tuberculosis prevention knowledge in a community in Lanxi City. Chin Rural Health Service Admin. 2016;36(1):86–8. (in Chinese).
61.
Wang N, Zhang H, Zhou Y, Jiang H, Dai B, Sun M, et al. Using electronic medication monitoring to guide differential management of tuberculosis patients at the community level in China. BMC Infect Dis. 2019;19(1):844.PubMedPubMedCentralCrossRef
62.
Tang SP. Application of standardized management of community tuberculosis patients. Med dietotherapy and health. 2020;18(16):185–6. (in Chinese).
63.
Li XF, Peng JM, Liu ZD, Feng JF, Xiao SH, Chen WJ, et al. Effectiveness evaluation of referral and follow-up on WeChat using “Mobile phone Integrated Management System for Tuberculosis Prevention and Treatment” for tuberculosis. Chin J Antituberc. 2020;42(8):858–62. (in Chinese).
64.
Yang WJ. Evaluation of the effect of community-supervised chemotherapy on pulmonary tuberculosis patients. World Latest Med Inform. 2021;21(72):364–5. (in Chinese).
65.
Wang JJ, Liu PH, Li MQ, Sun SH. Research on supervision and management of tuberculosis patients based on WeChat platform. Chin Med Equipm. 2021;18(2):110–4. (in Chinese).
66.
Shi YY. Qualitative study on satisfaction of tuberculosis management system assisted by mobile application. Health Educ and Health Prom. 2021;16(2):194. 196,220 (in Chinese).
67.
Huang MR, Jin YQ, Yan PJ. The effect of the multi-dimensional health education pattern based on informationtechnology on the awareness and behavior of tuberculosis among high school students. Prim Care Med Forum. 2021;25(16):2355–7. (in Chinese).
68.
Li X, Wang B, Tan D, Li M, Zhang D, Tang C, et al. Effectiveness of comprehensive social support interventions among elderly patients with tuberculosis in communities in China: a community-based trial. J Epidemiol Community Health. 2018;72(5):369–75.PubMedCrossRef
69.
Chen Y, Tan D, Xu Y, Wang B, Li X, Cai X, et al. Effects of a HAPA-based multicomponent intervention to improve self-management precursors of older adults with tuberculosis: a community-based randomised controlled trial. Patient Educ Couns. 2020;103(2):328–35.PubMedCrossRef
70.
Zhou JH. Study on the role of health education in tuberculosis control. Contemp Med. 2016;22(12):6–7. (in Chinese).
71.
Fu WQ, Liu GX, Wu QH, Hao M. Analysis on health financial resources allocation in primary medical institutions of China since the implementation of new medical reform. Chin Health Econ. 2015;34(9):51–2. (in Chinese).
72.
Wang L, Xu C, Hu M, Qiao J, Chen W, Li T, et al. Spatio-temporal variation in tuberculosis incidence and risk factors for the disease in a region of unbalanced socio-economic development. BMC Public Health. 2021;21(1):1817.PubMedPubMedCentralCrossRef
73.
You SX. Problems and countermeasures in primary tuberculosis prevention and control. Hum Health. 2016;(16):272 (in Chinese).
74.
Li Y, Ehiri J, Tang S, Li D, Bian Y, Lin H, et al. Factors associated with patient, and diagnostic delays in chinese TB patients: a systematic review and meta-analysis. BMC Med. 2013;11:156.PubMedPubMedCentralCrossRef
75.
Spruijt I, Haile DT, van den Hof S, Fiekert K, Jansen N, Jerene D, et al. Knowledge, attitudes, beliefs, and stigma related to latent tuberculosis infection: a qualitative study among Eritreans in the Netherlands. BMC Public Health. 2020;20(1):1602.PubMedPubMedCentralCrossRef
76.
Xu ZW, Yang YG, Zhang XJ, Qin SY, Wang MY. Investigation of cognitive status of inpatients on the current hierarchical diagnosis and treatment system and the influencing factors. Henan Med Research. 2017;26(16):2887–90. (in Chinese).
77.
Chen S, Zhang H, Pan Y, Long Q, Xiang L, Yao L, et al. Are free anti-tuberculosis drugs enough? An empirical study from three cities in China. Infect Dis Poverty. 2015;4:47.PubMedPubMedCentralCrossRef
78.
Siroka A, Ponce NA, Lönnroth K. Association between spending on social protection and tuberculosis burden: a global analysis. Lancet Infect Dis. 2016;16:473–9.PubMedCrossRef
79.
80.
Zhang G, Yu Y, Zhang W, Shang J, Chen S, Pang X, et al. Influence of COVID-19 for delaying the diagnosis and treatment of pulmonary tuberculosis-Tianjin, China. Front Public Health. 2022;10:937844.PubMedPubMedCentralCrossRef
81.
Chen J, Lin Z, Li LA, Li J, Wang Y, Pan Y, et al. Ten years of China’s new healthcare reform: a longitudinal study on changes in health resources. BMC Public Health. 2021;21(1):2272.PubMedPubMedCentralCrossRef
82.
Liang S, Deng H, Liu S, Wang G, Li L, Wang M, et al. Competency building for lay health workers is an intangible force driving basic public health services in Southwest China. BMC Health Serv Res. 2019;19(1):596.PubMedPubMedCentralCrossRef
83.
Zumla A, Marais BJ, McHugh TD, Maeurer M, Zumla A, Kapata N, et al. COVID-19 and tuberculosis-threats and opportunities. Int J Tuberc Lung Dis. 2020;24(8):757–60.PubMedCrossRef
84.
Li J, Liu XQ, Jiang SW, Li X, Yu F, Wang Y, et al. Improving tuberculosis case detection in underdeveloped multi-ethnic regions with high disease burden: a case study of integrated control program in China. Infect Dis Poverty. 2017;6(1):151.PubMedPubMedCentralCrossRef
85.
86.
World Health Organization. Towards people-centred health systems: an innovative approach for better health outcomes. Copenhagen: WHO; 2013.
87.
88.
Wei X, Hicks JP, Pasang P, Zhang Z, Haldane V, Liu X, et al. Protocol for a randomised controlled trial to evaluate the effectiveness of improving tuberculosis patients’ treatment adherence via electronic monitors and an app versus usual care in Tibet. Trials. 2019;20(1):273.PubMedPubMedCentralCrossRef
89.
Office of Chinese National Health Committee. Technical Specifications for Tuberculosis Prevention and Control in China. (2020). Chinese National Health Committee. 2020. http:/ / tb. chinacdc. cn/ ggl/202004/ P020200414515703939844.pdf. Accessed 17 Oct 2021.
90.
Peters DH, Adam T, Alonge O, Agyepong IA, Tran N. Republished research: implementation research: what it is and how to do it. Br J of Sports Med. 2014;48:731–6.CrossRef
91.
Rasanathan K, Tran N, Johnson HL, Hafeez A, Peterson S, Ghaffar A. Realizing the potential of embedded implementation research: Lessons from Pakistan. J Glob Health. 2020;10(2):020104.PubMedPubMedCentralCrossRef
92.
Feldstein AC, Glasgow RE. A practical, robust implementation and sustainability model (PRISM) for integrating research findings into practice. Jt Comm J Qual Patient Saf. 2008;34:228–43.PubMed
93.
Metadata
Title
Challenge of ending TB in China: tuberculosis control in primary healthcare sectors under integrated TB control model–a systematic review and meta-analysis
Authors
Xi Chen
Jiani Zhou
Quan Yuan
Rui Zhang
Chunji Huang
Ying Li
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2024
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-023-16292-5

Other articles of this Issue 1/2024

BMC Public Health 1/2024 Go to the issue

Research

Predictors of quitting support from nonsmoking mothers for smoking fathers: a cross-sectional study from Chinese pupils’ families

Research

COVID-19 vaccine intentions and attitudes in Black American emerging adults with asthma

Research

Psychometrics of the breastfeeding self-efficacy scale and short form: a systematic review

Research

Physical and psychosocial challenges of people with gender dysphoria: a content analysis study

Research

Centering PrEP: utilizing ADAPT-ITT to inform group PrEP care for sex workers in Chicago

Research

Prevalence and predictors of self-reported hearing aid use and benefit in Norway: the HUNT study